Concepedia

Kristen Sweet

KS

10

Publications

609

Citations

10

H-Index

2018

Active since

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

University of Glasgow

Drexel University

University of California, San Francisco

Kristen Sweet is an author at Janssen (United States) specializing in autoimmune disease, rheumatoid arthritis, and rheumatology.

Top concepts

Publications per year

2018–2023

10

Publications

10

Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

Atul Deodhar, Lianne S. Gensler, Joachim Sieper et al. · Arthritis & Rheumatology · 2018 · 311 citations · Full text

Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies

Philip J. Mease, Philip Helliwell, Dafna D. Gladman et al. · The Lancet Rheumatology · 2021 · 94 citations

, , +13

Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials

Philip Helliwell, Dafna D. Gladman, Soumya D. Chakravarty et al. · RMD Open · 2020 · 57 citations · Full text

Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials

Kristen Sweet, Qingxuan Song, Matthew J. Loza et al. · RMD Open · 2021 · 36 citations · Full text

Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus

Matteo Cesaroni, Loqmane Seridi, Matthew J. Loza et al. · Arthritis & Rheumatology · 2020 · 25 citations · Full text

Rows per page

1–5 of 10